Sub-Saharan Africa (excluding high income) vs Uganda: Antiretroviral therapy coverage for PMTCT
Sub-Saharan Africa (excluding high income)
89.5%
in 2024
Uganda
100.0%
in 2024
Sub-Saharan Africa (excluding high income) rank
2nd
Uganda rank
1st
Antiretroviral therapy coverage for PMTCT over time
- Sub-Saharan Africa (excluding high income)
- Uganda
How they compare
Uganda currently reports 100.0% against 89.5% in Sub-Saharan Africa (excluding high income), a difference of 10.5%.
That makes Uganda's figure about 1.1 times Sub-Saharan Africa (excluding high income)'s.
The two have swapped places 5 times across 25 shared years of data; in 2000 it was Sub-Saharan Africa (excluding high income) ahead.
Sub-Saharan Africa (excluding high income) ranks 2nd and Uganda ranks 1st of 15 groups.
Uganda has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Sub-Saharan Africa (excluding high income) | Uganda | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 20.9% | 21.8% | 0.9% | Uganda |
| 2010s | 78.2% | 89.8% | 11.6% | Uganda |
| 2020s | 88.6% | 98.8% | 10.2% | Uganda |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher antiretroviral therapy coverage for pmtct, Sub-Saharan Africa (excluding high income) or Uganda?
- Uganda, at 100.0% against 89.5% in Sub-Saharan Africa (excluding high income) as of 2024.
- What is the difference in antiretroviral therapy coverage for pmtct between Sub-Saharan Africa (excluding high income) and Uganda?
- 10.5%, with Uganda ahead.
- How many years of comparable data are there for Sub-Saharan Africa (excluding high income) and Uganda?
- 25 years are reported by both, from 2000 to 2024.
- How do Sub-Saharan Africa (excluding high income) and Uganda rank globally for antiretroviral therapy coverage for pmtct?
- Sub-Saharan Africa (excluding high income) ranks 2nd and Uganda ranks 1st of 15 groups.
- Where does this data come from?
- UNAIDS estimates, Joint United Nations Programme on HIV/AIDS (UNAIDS), published as Antiretroviral therapy coverage for PMTCT (% of pregnant women living with HIV). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Percentage of pregnant women with HIV who receive antiretroviral medicine for prevention of mother-to-child transmission (PMTCT).